
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
β-casein CRISPR/Cas9 KO Plasmid (m) | sc-419848 | 20 µg | $397.00 |
Csn2 encodes mouse β-casein, a major secreted phosphoprotein of mammary epithelial cells that contributes to casein micelle assembly and calcium–phosphate transport in milk. Its expression is tightly regulated during pregnancy and lactation by prolactin and glucocorticoid signaling, prominently through JAK2/STAT5 and cooperating transcriptional programs that coordinate mammary gland differentiation and secretory function. Because β-casein is a canonical marker of lactogenic differentiation, perturbation of Csn2 is widely used to interrogate endocrine control of epithelial maturation, protein secretion, and calcium homeostasis. Altered casein gene regulation is also informative for modeling dysregulated mammary developmental states and for assessing how hormonal and inflammatory cues reshape the milk protein transcriptome.
β-casein CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Csn2 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Csn2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Csn2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish β-casein protein expression.
This CRISPR knockout system enables efficient generation of Csn2-deficient cell models for investigation of β-casein signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.